Publications by authors named "Jan Diekmann"

Claim this Profile
A
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.
Juanita Lopez, Thomas Powles, Fadi Braiteh, Lillian L Siu, Patricia LoRusso, Jan Diekmann

Nat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drops on Polymer Brushes: Advances in Thin-Film Modeling of Adaptive Substrates.
Simon Hartmann, Jan Diekmann, Daniel Greve, Uwe Thiele

Langmuir· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody.
Hayat Bähr-Mahmud, Ursula Ellinghaus, Christiane R Stadler, Leyla Fischer, Claudia Lindemann, Jan Diekmann

Oncoimmunology· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicological Assessments of a Pandemic COVID-19 Vaccine-Demonstrating the Suitability of a Platform Approach for mRNA Vaccines.
Cynthia M Rohde, Claudia Lindemann, Michael Giovanelli, Rani S Sellers, Jan Diekmann

Vaccines (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models.
Christian Hotz, Timothy R Wagenaar, Friederike Gieseke, Dinesh S Bangari, Michelle Callahan, Jan Diekmann

Sci Transl Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine.
Christopher J Bowman, Marie Bouressam, Sarah N Campion, Gregg D Cappon, Natasha R Catlin, Jan Diekmann

Reprod Toxicol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.
Ugur Sahin, Evelyna Derhovanessian, Matthias Miller, Björn-Philipp Kloke, Petra Simon, Jan Diekmann

Nature· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.
Lena M Kranz, Mustafa Diken, Heinrich Haas, Sebastian Kreiter, Carmen Loquai, Jan Diekmann

Nature· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer.
Sebastian Kreiter, Mathias Vormehr, Niels van de Roemer, Mustafa Diken, Martin Löwer, Jan Diekmann

Nature· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant MHC class II epitopes drive therapeutic immune responses to cancer.
Sebastian Kreiter, Mathias Vormehr, Niels van de Roemer, Mustafa Diken, Martin Löwer, Jan Diekmann

Nature· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A vaccine targeting mutant IDH1 induces antitumour immunity.
Theresa Schumacher, Lukas Bunse, Stefan Pusch, Felix Sahm, Benedikt Wiestler, Jan Diekmann

Nature· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR inhibition improves antitumor effects of vaccination with antigen-encoding RNA.
Mustafa Diken, Sebastian Kreiter, Fulvia Vascotto, Abderraouf Selmi, Sebastian Attig, Jan Diekmann

Cancer Immunol Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting the mutanome for tumor vaccination.
John C Castle, Sebastian Kreiter, Jan Diekmann, Martin Löwer, Niels van de Roemer

Cancer Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines.
Sebastian Kreiter, Mustafa Diken, Abderraouf Selmi, Jan Diekmann, Sebastian Attig

Cancer Res· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement.
Jan Diekmann, Eleni Adamopoulou, Olaf Beck, Georg Rauser, Sarah Lurati

J Immunol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response.
Eleni Adamopoulou, Jan Diekmann, Eva Tolosa, Gaby Kuntz, Hermann Einsele

J Immunol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis